Abstract
Objectives
To investigate the prognostic value of baseline musculoskeletal ultrasound (MSUS) findings for rheumatoid arthritis (RA).
Method
We retrospectively analyzed 138 patients with RA. Patients’ first MSUS record was considered as the baseline expression. The subsequent MSUS changes that showed alleviation or progression were regarded as the cutoff point. Grayscale ultrasound (GSUS) synovitis, power Doppler ultrasound (PDUS) synovitis, PDUS tenosynovitis (TS), and bone erosion were scored using a semi-quantitative scale. According to the ultrasound (US) results of the cutoff point, patients were divided into the alleviation group and the progression group. Laboratory results (erythrocyte sedimentation rate [ESR], C-reactive protein [CRP], rheumatoid factor [RF], anticyclic citrullinated peptide [anti-CCP] antibody, and anti-keratin antibody [AKA]), disease activity score in 28 joints (DAS28)-ESR, and US scores were compared between the two groups to analyze the prognostic value of US findings in RA.
Results
The alleviation group had higher levels of CRP, synovitis, TS, GSUS synovitis, PDUS synovitis, PDUS TS, and US total scores at baseline than the progression group (p < 0.05). The alleviation group received more aggressive treatment in their initial approach than the progression group (p < 0.05). The frequency of US examinations in the alleviation group was more than that in the progression group at follow-up (p < 0.05). Presence of baseline synovitis (OR 0.248, p = 0.006) and a higher GSUS synovitis score (OR 0.521, p = 0.006) were negatively correlated with RA progression.
Conclusions
Presence of baseline synovitis and higher GSUS synovitis score do not always indicate worse prognosis of RA, which can be improved with aggressive treatment. Regular MSUS follow-up may have positive influences on prognosis.
Key Points • The presence of synovitis at baseline and higher GSUS synovitis score do not necessarily imply poor prognosis of RA. • Prompt and powerful therapy and regular ultrasound follow-up can slow down the progression of RA and improve its prognosis. • Patients with slight and less arthritis at baseline might be ignored and get worse prognosis due to mild treatment strategies and irregular MSUS examination. |
Similar content being viewed by others
Data availability
The dataset used and/or analyzed during the current study is available from the corresponding author on reasonable request.
Change history
28 January 2022
A Correction to this paper has been published: https://doi.org/10.1007/s10067-022-06083-5
References
Smolen JS, Landewe R, Bijlsma J, Burmester G, Chatzidionysiou K, Dougados M et al (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960–977. https://doi.org/10.1136/annrheumdis-2016-210715
Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A et al (2020) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis 79(6):685–699. https://doi.org/10.1136/annrheumdis-2019-216655
Möller I, Loza E, Uson J, Acebes C, Andreu JL, Batlle E et al (2018) Recommendations for the use of ultrasound and magnetic resonance in patients with rheumatoid arthritis. Reumatol Clin (Engl Ed) 14(1):9–19. https://doi.org/10.1016/j.reuma.2016.08.010
Zayat AS, Ellegaard K, Conaghan PG, Terslev L, Hensor EM, Freeston JE et al (2015) The specificity of ultrasound-detected bone erosions for rheumatoid arthritis. Ann Rheum Dis 74(5):897–903. https://doi.org/10.1136/annrheumdis-2013-204864
Iwamoto T, Ikeda K, Hosokawa J, Yamagata M, Tanaka S, Norimoto A et al (2014) Prediction of relapse after discontinuation of biologic agents by ultrasonographic assessment in patients with rheumatoid arthritis in clinical remission: high predictive values of total gray-scale and power Doppler scores that represent residual synovial inflammation before discontinuation. Arthritis Care Res (Hoboken) 66(10):1576–1581. https://doi.org/10.1002/acr.22303
Nam JL, Hensor EM, Hunt L, Conaghan PG, Wakefield RJ, Emery P (2016) Ultrasound findings predict progression to inflammatory arthritis in anti-CCP antibody-positive patients without clinical synovitis. Ann Rheum Dis 75(12):2060–2067. https://doi.org/10.1136/annrheumdis-2015-208235
Han J, Geng Y, Deng X, Zhang Z (2016) Subclinical synovitis assessed by ultrasound predicts flare and progressive bone erosion in rheumatoid arthritis patients with clinical remission: a systematic review and metaanalysis. J Rheumatol 43(11):2010–2018. https://doi.org/10.3899/jrheum.160193
Di Matteo A, Mankia K, Duquenne L, Cipolletta E, Wakefield RJ, Garcia-Montoya L et al (2020) Ultrasound erosions in the feet best predict progression to inflammatory arthritis in anti-CCP positive at-risk individuals without clinical synovitis. Ann Rheum Dis 79(7):901–907. https://doi.org/10.1136/annrheumdis-2020-217215
El Miedany Y, El Gaafary M, Youssef S, Ahmed I, Bahlas S, Hegazi M et al (2016) Optimizing therapy in inflammatory arthritis: prediction of relapse after tapering or stopping treatment for rheumatoid arthritis patients achieving clinical and radiological remission. Clin Rheumatol 35(12):2915–2923. https://doi.org/10.1007/s10067-016-3413-8
van Beers-Tas MH, Blanken AB, Nielen MMJ, Turkstra F, van der Laken CJ, Meursinge Reynders M et al (2018) The value of joint ultrasonography in predicting arthritis in seropositive patients with arthralgia: a prospective cohort study. Arthritis Res Ther 20(1):279. https://doi.org/10.1186/s13075-018-1767-9
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324. https://doi.org/10.1002/art.1780310302
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569–2581. https://doi.org/10.1002/art.27584
Backhaus M, Burmester GR, Gerber T, Grassi W, Machold KP, Swen WA et al (2001) Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis 60(7):641–649. https://doi.org/10.1136/ard.60.7.641
Backhaus MBG, Gerber T et al (2001) Guidelines for musculoskeletal ultrasound in rheumatology. Ann Rheum Dis 60(7):641–649
Szkudlarek M, Court-Payen M, Jacobsen S, Klarlund M, Thomsen HS, Ostergaard M (2003) Interobserver agreement in ultrasonography of the finger and toe joints in rheumatoid arthritis. Arthritis Rheum 48(4):955–962. https://doi.org/10.1002/art.10877
Ammitzboll-Danielsen M, Ostergaard M, Naredo E, Terslev L (2016) Validity and sensitivity to change of the semi-quantitative OMERACT ultrasound scoring system for tenosynovitis in patients with rheumatoid arthritis. Rheumatology (Oxford) 55(12):2156–2166. https://doi.org/10.1093/rheumatology/kew317
Nawata M, Saito K, Fukuyo S, Hirata S, Tanaka Y (2016) Clinically relevant radiographic progression in joint destruction in RA patients with abnormal MMP-3 or high levels of CRP despite 1-year treatment with infliximab. Mod Rheumatol 26(6):807–812. https://doi.org/10.3109/14397595.2016.1158386
Carpenter L, Nikiphorou E, Sharpe R, Norton S, Rennie K, Bunn F et al (2016) Have radiographic progression rates in early rheumatoid arthritis changed? A systematic review and meta-analysis of long-term cohorts. Rheumatology (Oxford) 55(6):1053–1065. https://doi.org/10.1093/rheumatology/kew004
Simpson E, Hock E, Stevenson M, Wong R, Dracup N, Wailoo A et al (2018) What is the added value of ultrasound joint examination for monitoring synovitis in rheumatoid arthritis and can it be used to guide treatment decisions? A systematic review and cost-effectiveness analysis. Health Technol Assess 22(20):1–258. https://doi.org/10.3310/hta22200
Colebatch AN, Edwards CJ, Østergaard M, van der Heijde D, Balint PV, D’Agostino MA et al (2013) EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis. Ann Rheum Dis 72(6):804–814. https://doi.org/10.1136/annrheumdis-2012-203158
Rydell E, Forslind K, Nilsson JA, Jacobsson LTH, Turesson C (2018) Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis. Arthritis Res Ther 20(1):82. https://doi.org/10.1186/s13075-018-1575-2
Rydell E, Forslind K, Nilsson JA, Karlsson M, Akesson KE, Jacobsson LTH et al (2021) Predictors of radiographic erosion and joint space narrowing progression in patients with early rheumatoid arthritis: a cohort study. Arthritis Res Ther 23(1):27. https://doi.org/10.1186/s13075-020-02413-7
Smolen JS, Kang YM, Yoo WH, Emery P, Weinblatt ME, Keystone EC et al (2020) Radiographic progression based on baseline characteristics from TNF inhibitor biosimilar studies in patients with rheumatoid arthritis. Arthritis Res Ther 22(1):188. https://doi.org/10.1186/s13075-020-02267-z
D’Agostino MA, Terslev L, Aegerter P, Backhaus M, Balint P, Bruyn GA et al (2017) Scoring ultrasound synovitis in rheumatoid arthritis: a EULAR-OMERACT ultrasound taskforce-Part 1: definition and development of a standardised, consensus-based scoring system. RMD Open 3(1):e000428. https://doi.org/10.1136/rmdopen-2016-000428
Ten Cate DF, Jacobs JWG, Swen WAA, Hazes JMW, de Jager MH, Basoski NM et al (2018) Can baseline ultrasound results help to predict failure to achieve DAS28 remission after 1 year of tight control treatment in early RA patients? Arthritis Res Ther 20(1):15. https://doi.org/10.1186/s13075-018-1514-2
Mankia K, Briggs C, Emery P (2020) How are rheumatologists managing anticyclic citrullinated peptide antibodies-positive patients who do not have arthritiS? J Rheumatol 47(2):305–306. https://doi.org/10.3899/jrheum.190211
Lukas C, Combe B, Ravaud P, Sibilia J, Landew R, van der Heijde D (2011) Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: data from the Étude et Suivi des polyarthrites indifférenciées récentes (study and followup of early undifferentiated polyarthritis). Arthritis Rheum 63(7):1804–1811. https://doi.org/10.1002/art.30371
Dale J, Stirling A, Zhang R, Purves D, Foley J, Sambrook M et al (2016) Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomised clinical trial. Ann Rheum Dis 75(6):1043–1050. https://doi.org/10.1136/annrheumdis-2015-208941
Dale J, Purves D, McConnachie A, McInnes I, Porter D (2014) Tightening up? Impact of musculoskeletal ultrasound disease activity assessment on early rheumatoid arthritis patients treated using a treat to target strategy. Arthritis Care Res (Hoboken) 66(1):19–26. https://doi.org/10.1002/acr.22218
Terslev L, Ostergaard M (2021) Rheumatoid arthritis relapse and remission—advancing our predictive capability using modern imaging. J Inflamm Res 14:2547–2555. https://doi.org/10.2147/jir.s284405
Ben Abdelghani K, Miladi S, Souabni L, Kassab S, Chekili S, Laatar A et al (2015) Role of ultrasound in assessing remission in rheumatoid arthritis. Diagn Interv Imaging 96(1):3–10. https://doi.org/10.1016/j.diii.2014.07.006
Funck-Brentano T, Gandjbakhch F, Etchepare F, Jousse-Joulin S, Miquel A, Cyteval C et al (2013) Prediction of radiographic damage in early arthritis by sonographic erosions and power Doppler signal: a longitudinal observational study. Arthritis Care Res (Hoboken) 65(6):896–902. https://doi.org/10.1002/acr.21912
Horton SC, Tan AL, Wakefield RJ, Freeston JE, Buch MH, Emery P (2017) Ultrasound-detectable grey scale synovitis predicts future fulfilment of the 2010 ACR/EULAR RA classification criteria in patients with new-onset undifferentiated arthritis. RMD Open 3(1):e000394. https://doi.org/10.1136/rmdopen-2016-000394
Möller B, Aletaha D, Andor M, Atkinson A, Aubry-Rozier B, Brulhart L et al (2020) Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years. Rheumatology (Oxford) 59(7):1556–1565. https://doi.org/10.1093/rheumatology/kez460
Sundin U, Sundlisater NP, Aga AB, Sexton J, Nordberg LB, Hammer HB et al (2021) Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy. RMD Open 7(1):e001525. https://doi.org/10.1136/rmdopen-2020-001525
Di Matteo A, Mankia K, Nam JL, Cipolletta E, Garcia-Montoya L, Duquenne L et al (2020) In anti-CCP+ at-risk individuals, radiographic bone erosions are uncommon and are not associated with the development of clinical arthritis. Rheumatology (Oxford) 60(7):3156–3164. https://doi.org/10.1093/rheumatology/keaa761
Kawashiri SY, Endo Y, Okamoto M, Tsuji S, Shimizu T, Sumiyoshi R et al (2021) Contributing factors of clinical outcomes at 1 year post-diagnosis in early rheumatoid arthritis patients with tightly controlled disease activity in clinical practice: a retrospective study. Mod Rheumatol 31(2):343–349. https://doi.org/10.1080/14397595.2020.1795392
Acknowledgements
The authors would like to thank all the participants’ involvement in this study.
Funding
This study was supported by the Medical Science Research Project of Hebei Province (20190528) and the Chinese Medicine Scientific Research Program of Hebei Province (2020171).
Author information
Authors and Affiliations
Contributions
CS, LL, and YY performed the US scans. XQ was responsible for the data collection. LG analyzed data. CS wrote the manuscript. HG was responsible for the study design. All authors contributed to revision of the report and approved the final version.
Corresponding author
Ethics declarations
Consent for publication
All authors gave their consent for publication.
Disclosures
None.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised due to a retrospective Open Access cancellation.
Rights and permissions
About this article
Cite this article
Sun, C., Qi, X., Yang, Y. et al. Importance of baseline musculoskeletal ultrasound findings in the prognosis of rheumatoid arthritis. Clin Rheumatol 41, 847–857 (2022). https://doi.org/10.1007/s10067-021-06017-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-021-06017-7